Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
(NASDAQ:HSDT), –128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants– –150 maximum participant enrollment projected by end of January– –The stroke registrational program is intended to demonstrate the safety and effectiveness of the novel Portable Neuromodulation Stimulator (PoNS(R)) for improving balance and gait deficits in stroke survivors– –On track for […]